Research progress of gut microbiota and its metabolites in polycystic ovary syndrome
Open Access
- 17 December 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1700191
Abstract
Polycystic ovary syndrome (PCOS) ranks among the most widespread endocrine and metabolic conditions affecting women of childbearing age, but its specific pathogenesis remains unknown. More and more evidence indicates that PCOS may be a complex polymorphic disease, influenced by epigenetic and environmental factors, including diet and lifestyle. This review focuses on the role of the gut microbiota and its metabolites in PCOS, a topic that has gained significant attention recently due to the established link between the gut microbiome and metabolic disorders.Keywords
This publication has 130 references indexed in Scilit:
- Gut microbial‐derived 3,4‐dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndromeiMeta, 2025
- Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary SyndromeAdvanced Science, 2025
- Exploring Mechanism of Electroacupuncture in Modulating Neuroinflammation Based on Intestinal Flora and Its MetabolitesChinese Journal of Integrative Medicine, 2024
- Efficacy of multi-strain probiotic along with dietary and lifestyle modifications on polycystic ovary syndrome: a randomised, double-blind placebo-controlled studyEuropean Journal of Nutrition, 2022
- Diagnosis and Treatment of Polycystic Ovary SyndromeJAMA, 2022
- Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndromeJournal of Cellular Physiology, 2020
- Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS ratsBioprocess and Biosystems Engineering, 2020
- Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?Seminars in Immunopathology, 2019
- An insight into gut microbiota and its functionalitiesCellular and Molecular Life Sciences, 2018
- Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolismHepatology, 2018